Povetacicept is an investigational dual BAFF and APRIL inhibitor being tested for various glomerulonephritis types in clinical trials.
The Cool Down on MSN
Former SpaceX engineers develop small nuclear reactors that could revolutionize energy industry: 'A major milestone'
"Completed numerous design reviews." Former SpaceX engineers develop small nuclear reactors that could revolutionize energy ...
Earlier today, Hyperfine, Inc. released financial results for the quarter ended September 30, 2025. Before we begin, I would ...
Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsWebb CampbellMaria Sainz - CEO, President & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback